FDA
Orphenadrine Citrate
The FDA lists this product in 13 strengths and forms.
Composition
- Active ingredients
- ORPHENADRINE CITRATE 30MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA091158-001 · Prescription
- ORPHENADRINE CITRATE 30MG/ML · InjectableANDA084779-001 · Prescription
- ORPHENADRINE CITRATE 30MG/ML · InjectableANDA087062-001 · Discontinued
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA085046-001 · Discontinued
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040327-001 · Prescription
- ORPHENADRINE CITRATE 30MG/ML · InjectableANDA040463-001 · Prescription
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA088067-001 · Discontinued
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040249-001 · Prescription
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040284-001 · Prescription
- ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA084303-001 · Discontinued
- ORPHENADRINE CITRATE 100MG · Tablet, extended release
At a glance
- Brand name
- Orphenadrine Citrate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Rising
- Status
- Prescription
- FDA approval
- 24 May 2006
- Application
- ANDA040484-001